Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | DRD4 | P21917 | 1/20 | 0.32 |
| ▸ | DRD3 | P35462 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7607951 | 1.00 | PNMT (0.39) | PNMTNPC1RAB9AHTR7HTR2B | |
| SCHEMBL6675362 | 0.99 | PNMT (0.38) | PNMTNPC1RAB9AHTR7HTR2B | |
| SCHEMBL6675358 | 0.99 | PNMT (0.38) | PNMTNPC1RAB9AHTR7HTR2B | |
| Hydrochloric Acid SCHEMBL8679932 | 0.97 | PNMT (0.37) | PNMTNPC1RAB9AHTR7HTR2B | |
| Hydrochloric Acid SCHEMBL9168322 | 0.97 | PNMT (0.37) | PNMTNPC1RAB9AHTR7HTR2B | |
| SCHEMBL8142261 | 0.84 | PNMT (0.35) | PNMTNPC1RAB9AHTR7HTR2B | |
| SCHEMBL5837265 | 0.83 | PNMT (0.49) | PNMTNPC1RAB9AHTR7HTR2B | |
| SCHEMBL7111382 | 0.82 | PNMT (0.36) | PNMTNPC1RAB9AHTR7HTR2B | |
| Hydrochloric Acid SCHEMBL8577952 | 0.80 | PNMT (0.33) | PNMTNPC1RAB9ADRD2DRD4 | |
| SCHEMBL28733067 | 0.80 | PNMT (0.33) | PNMTNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 279 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5670681-A | Process for preparing a carbon-bridged biscyclopentadiene compound | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-09-23 | — | — | US | claimed |
| EP-0548274-B1 | IONIC CATALYST FOR THE PRODUCTION OF POLY-ALPHA-OLEFINS OF CONTROLLED TACTICITY | EXXON CHEMICAL PATENTS INC (US) | 1996-02-28 | — | — | EP | claimed |
| EP-0548274-A1 | IONIC CATALYST FOR THE PRODUCTION OF POLY--g(a)-OLEFINS OF CONTROLLED TACTICITY. | EXXON CHEMICAL PATENTS INC (US) | 1993-06-30 | — | — | EP | claimed |
| WO-1992005208-A1 | IONIC CATALYST FOR THE PRODUCTION OF POLY-α-OLEFINS OF CONTROLLED TACTICITY | EXXON CHEMICAL PATENTS INC. (US) | 1992-04-02 | — | — | WO | claimed |
| US-12590174-B2 | Curable compositions comprising telechelic polyolefins | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-03-31 | — | — | US | disclosed |
| EP-3902808-B1 | CURABLE COMPOSITIONS COMPRISING UNSATURATED POLYOLEFINS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-01-14 | — | — | EP | disclosed |
| EP-3902810-B1 | CURABLE COMPOSITIONS COMPRISING TELECHELIC POLYOLEFINS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-01-14 | — | — | EP | disclosed |
| EP-3356374-B1 | MULTI- OR DUAL-HEADED COMPOSITIONS USEFUL FOR CHAIN SHUTTLING AND PROCESS TO PREPARE THE SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-09-24 | — | — | EP | disclosed |
| EP-3902807-B1 | ORGANOMETALLIC CHAIN TRANSFER AGENTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-07-09 | — | — | EP | disclosed |
| US-12351707-B2 | Curable compositions comprising unsaturated polyolefins | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-07-08 | — | — | US | disclosed |
| US-12275810-B2 | Telechelic polyolefins and processes for preparing the same | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-04-15 | — | — | US | disclosed |
| US-12180314-B2 | Curable compositions comprising unsaturated polyolefins | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-12-31 | — | — | US | disclosed |
| EP-0574258-A2 | Process for producing alpha-olefin polymers | MITSUBISHI CHEMICAL CORPORATION (JP) | 1993-12-15 | — | — | EP | disclosed |
| US-5252677-A | Epoxy, hydroxy or sulfonic acid end groups | MITSUBISHI PETROCHEMICAL COMPANY LIMITED (JP) | 1993-10-12 | — | — | US | disclosed |
| US-5225501-A | Transition metal compound and alumoxane catalyst | MITSUBISHI PETROCHEMICAL COMPANY LIMITED (JP) | 1993-07-06 | — | — | US | disclosed |
| EP-0538749-A1 | Propylene copolymer composition | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1993-04-28 | — | — | EP | disclosed |
| EP-0512741-A1 | Process for producing a propylene random copolymer | MITSUBISHI CHEMICAL CORPORATION (JP) | 1992-11-11 | — | — | EP | disclosed |
| EP-0498675-A2 | Production of alpha-olefin polymers | MITSUBISHI CHEMICAL CORPORATION (JP) | 1992-08-12 | — | — | EP | disclosed |
| EP-0487278-A2 | Functionalized olefin polymers | MITSUBISHI CHEMICAL CORPORATION (JP) | 1992-05-27 | — | — | EP | disclosed |
| EP-0462588-A2 | Olefin block copolymer and method of producing same | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1991-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590174-B2 | Curable compositions comprising telechelic polyolefins | CCT2, TCP1, ECH1 | PNMT 1496/4885NPC1 3703/4885RAB9A 4811/4885 |
| US-12351707-B2 | Curable compositions comprising unsaturated polyolefins | ACSL6, ELOVL6, ALOX5 | PNMT 3858/4885NPC1 1682/4885RAB9A 4806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.